Literature DB >> 20305620

New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.

Concha Lopez-Gines1, Rosario Gil-Benso, Ruben Ferrer-Luna, Rafael Benito, Eva Serna, Jose Gonzalez-Darder, Vicente Quilis, Daniel Monleon, Bernardo Celda, Miguel Cerdá-Nicolas.   

Abstract

Gene amplification is a process that is characterized by an increase in the copy number of a restricted region in a chromosome arm, and is frequently associated with an overexpression of the corresponding amplified gene. Amplified DNA can be organized either as extrachromosomal elements, repeated units at a single locus or scattered throughout the genome. The amplification of the gene for epidermal growth factor receptor (EGFR) is a common finding in glioblastomas and the amplified gene copies appears as double minutes. The aim of this study was to investigate the different patterns of EGFR amplification in 40 cases of glioblastoma using FISH analysis in metaphases and paraffin sections, and to investigate the relationship of gene copy number with gene expression profile. The analysis of copy number alterations of EGFR was validated by quantitative PCR and SNP microarrays. We observed that in 42% of the cases, the type of amplification of EGFR was as double minute chromosomes. In addition, we detected another type of amplification, with extra copies of EGFR inserted in different loci of chromosome 7, present in 28% of cases. In this form of amplification, the number of copies is small, and the percentage of cells with EGFR amplification is rarely more than 15%. This model of amplification could correspond to a variant of the insertion mechanism, or a consequence of a process of duplication. Our results suggest that this mechanism could represent an early stage of amplification in glioblastomas. Overall, we found a close correlation between EGFR gene copy-number alterations and the level of EGFR protein expression. However, all cases with a high level of mRNA exhibited strong expression for the EGFR protein, and most cases with a low level of mRNA showed no overexpression of EGFR protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305620     DOI: 10.1038/modpathol.2010.62

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  37 in total

1.  Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.

Authors:  Concha López-Ginés; Lara Navarro; Lisandra Muñoz-Hidalgo; Enrique Buso; José Manuel Morales; Rosario Gil-Benso; Mariela Gregori-Romero; Javier Megías; Pedro Roldán; Remedios Segura-Sabater; José Manuel Almerich-Silla; Daniel Monleón; Miguel Cerdá-Nicolás
Journal:  Cell Oncol (Dordr)       Date:  2017-06-19       Impact factor: 6.730

2.  Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

Authors:  Inês Crespo; Ana Luísa Vital; Ana Belen Nieto; Olinda Rebelo; Hermínio Tão; Maria Celeste Lopes; Catarina Resende Oliveira; Pim J French; Alberto Orfao; María Dolores Tabernero
Journal:  J Mol Diagn       Date:  2011-08-30       Impact factor: 5.568

3.  Gene-protein correlation in single cells.

Authors:  Jaclyn J Renfrow; Adrienne C Scheck; Neil S Dhawan; Paul J Lukac; Hannes Vogel; James P Chandler; Jeffrey J Raizer; Griffith R Harsh; Arnab Chakravarti; Markus Bredel
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

4.  Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.

Authors:  Karl B Gregory; Amin A Momin; Kevin R Coombes; Veerabhadran Baladandayuthapani
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2014-05-19       Impact factor: 3.710

5.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

6.  Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.

Authors:  Nicholas J Szerlip; Alicia Pedraza; Debyani Chakravarty; Mohammad Azim; Jeremy McGuire; Yuqiang Fang; Tatsuya Ozawa; Eric C Holland; Jason T Huse; Suresh Jhanwar; Margaret A Leversha; Tom Mikkelsen; Cameron W Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-08       Impact factor: 11.205

7.  A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel.

Authors:  Patrick J Cimino; Andy Bredemeyer; Haley J Abel; Eric J Duncavage
Journal:  Exp Mol Pathol       Date:  2015-04-22       Impact factor: 3.362

8.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

9.  Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.

Authors:  Dayane B Koshiyama; Patrícia Trevisan; Carla Graziadio; Rafael F M Rosa; Bibiana Cunegatto; Juliete Scholl; Valentina O Provenzi; Alexandre P de Sá; Fabiano P Soares; Maíra C Velho; Nelson de A P Filho; Ceres A Oliveira; Paulo R G Zen
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

10.  Protein residues that control the reaction trajectory in S-adenosylmethionine radical enzymes: mutagenesis of asparagine 153 and aspartate 155 in Escherichia coli biotin synthase.

Authors:  Christine E Farrar; Joseph T Jarrett
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.